ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures

May 21, 1993

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006

ASCO to form commission to study tobacco problem.

January 23, 2004

Philadelphia Firm Wins CIDAC Award

August 24, 1984

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992